Riskpilot← Back to searchSign inGet full accessAPOBUTIK ApS
APSBankruptCVR 32362923Kollundvej 6Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20094 employees
Revenue 2017
DKK -291K
+214% vs 2016
EBITDA margin
389.6%
-1124% vs 2016
Equity ratio
-37.9%
Financial strength
Net profit 2017
DKK -881K
-1049% vs 2016
| Revenue | DKK -291K | +214% |
| EBITDA | DKK -1,1M | -1124% |
| Net profit | DKK -881K | -1049% |
| Total assets | DKK 3M | +505% |
| Equity | DKK -1,1M | -359% |
| Employees | 4 | — |
Legal name
APOBUTIK ApS
CVR number
32362923
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
12. august 2009
Share capital
DKK 125.000
Employees
4 (FTE)
VAT registered
No
Audit selected
No
Last report
2017-07-31
Financial year
January – December
Signatory rights
Virksomheden tegnes af en likvidator
Address
Kollundvej 6
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
|---|---|---|---|---|---|---|
| Revenue | -114 | 4 | -145 | 74 | -93 | -291 |
| Staff expenses | -0 | -156 | -23 | -0 | -0 | -843 |
| EBITDA | -114 | -152 | -168 | 74 | -93 | -1.134 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | -114 | -152 | -168 | 74 | -93 | -1.134 |
| Net financials | -0 | -1 | -3 | 0 | 0 | 4 |
| Profit before tax | -114 | -153 | -171 | 74 | -93 | -1.130 |
| Tax | -28 | -38 | -40 | 36 | -16 | -249 |
| Net profit | -86 | -114 | -131 | 38 | -77 | -881 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 |
|---|---|---|---|---|---|---|
| Total assets | 230 | 451 | 625 | 1.338 | 491 | 2.973 |
| Equity | 38 | -76 | -207 | -169 | -246 | -1.127 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 192 | 527 | 832 | 1.507 | 737 | 4.100 |
| Total debt | 192 | 527 | 832 | 1.507 | 737 | 4.100 |
EBITDA margin
-113353500.0%
This company
15.8%
Market median
-717427315% vs market
20122017
Equity ratio
-37.9%
This company
38.2%
Market median
-199% vs market
20122017
Return on equity
-88144500.0%
This company
18.4%
Market median
-479046296% vs market
20122017
Net profit margin
-88144500.0%
This company
8.1%
Market median
-1088203804% vs market
20122017
Asset turnover
-0.10×
This company
1.12×
Market median
-109% vs market
20122017
Debt / equity
3.64×
This company
0.62×
Market median
-487% vs market
20122017
- Annual report 2017Filed via CVR / Virk · Period 2016-08-01 – 2017-07-31
- Annual report 2016Filed via CVR / Virk · Period 2015-08-01 – 2016-07-31
- Annual report 2015Filed via CVR / Virk · Period 2014-08-01 – 2015-07-31
- Annual report 2014Filed via CVR / Virk · Period 2013-08-01 – 2014-07-31
- Annual report 2013Filed via CVR / Virk · Period 2012-08-01 – 2013-07-31
- Annual report 2012Filed via CVR / Virk · Period 2011-08-01 – 2012-07-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
HS Unofficial title | Unofficial title | 2019 | — | — |
WR Management | Management | 2018 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
PINONLINE ApS | Company | 25.0% | 25.0% | 2017 |
| Individual | 25.0% | 25.0% | 2016 | |
PALMGATE ApS | Company | 50.0% | 50.0% | 2015 |
| Individual | 25.0% | 25.0% | 2012 | |
| Individual | 25.0% | 25.0% | 2018 | |
Ansari Holding ApS | Company | 25.0% | 25.0% | 2013 |
POUL SCHMIDT HOLDING ApS | Company | 25.0% | 25.0% | 2016 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of APOBUTIK ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Henrik Sjørslev | Unofficial title | 0 companies |
| Wahied Riaz | Management | 0 companies |